Abstract
New insights about the following aspects of lupus erythematosus are developed: (1) thrombotic and neurological manifestations associated with the presence of antiphospholipid antibodies; (2) cardiac complications, especially coronary ischemia, conduction abnormalities and valvular involvement; (3) pregnancy, with particular attention to fetal and maternal prognoses, Soulier-Boffa syndrome and congenital atrioventricular heart blocks; (4) subacute lupus erythematosus, bullous lupus and cutaneous manifestations associated with the lupus anticoagulant.
MeSH terms
-
Abortion, Spontaneous / etiology
-
Antibodies / analysis
-
Antibodies, Antinuclear / analysis
-
Blood Coagulation Factors / analysis
-
Blood Coagulation Factors / immunology
-
Female
-
Heart Block / congenital
-
Heart Diseases / etiology
-
Humans
-
Lupus Coagulation Inhibitor
-
Lupus Erythematosus, Systemic / blood
-
Lupus Erythematosus, Systemic / complications*
-
Lupus Erythematosus, Systemic / immunology
-
Phospholipids / immunology
-
Pregnancy
-
Pregnancy Complications
-
Skin Diseases / blood
-
Skin Diseases / etiology
Substances
-
Antibodies
-
Antibodies, Antinuclear
-
Blood Coagulation Factors
-
Lupus Coagulation Inhibitor
-
Phospholipids
-
SS-A antibodies